St. Jude Medical (STJ) Launches ADO II AS Trial to Study Congenital Heart Defects

October 18, 2016 9:04 AM EDT Send to a Friend
St. Jude Medical, Inc. (NYSE: STJ) announced the launch of the ADO II AS (AMPLATZERâ„¢ Duct Occluder II Additional Sizes) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login